Mersana Therapeutics Ownership | Who Owns Mersana Therapeutics?
Mersana Therapeutics Ownership Summary
Mersana Therapeutics is owned by 82.62% institutional investors, 1.51% insiders, and 15.87% retail investors. Nextech invest is the largest institutional shareholder, holding 9.83% of MRSN shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.78% of its assets in Mersana Therapeutics shares.
MRSN Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Mersana Therapeutics | 82.62% | 1.51% | 15.87% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Nextech invest | 12.07M | 9.83% | $17.26M |
Ecor1 capital | 11.33M | 9.23% | $16.20M |
Vr adviser | 10.26M | 8.36% | $14.67M |
Blackrock funding, inc. /de | 9.21M | 7.50% | $13.16M |
Bain capital life sciences investors | 8.66M | 7.06% | $12.39M |
Blackrock | 8.38M | 6.90% | $16.85M |
Vanguard group | 7.06M | 5.75% | $10.09M |
Novo | 4.25M | 3.46% | $6.08M |
Rock springs capital management lp | 3.43M | 2.80% | $4.91M |
State street | 2.68M | 2.21% | $5.39M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Nextech invest | 12.07M | 2.80% | $17.26M |
Acuta capital partners | 1.12M | 1.61% | $1.60B |
Bain capital life sciences investors | 8.66M | 1.46% | $12.39M |
Vr adviser | 10.26M | 1.01% | $14.67M |
Ecor1 capital | 11.33M | 0.61% | $16.20M |
5am venture management | 1.30M | 0.45% | $1.87M |
Novo | 4.25M | 0.37% | $6.08M |
Healthinvest partners ab | 538.62K | 0.36% | $764.84K |
Octagon capital advisors lp | 992.00K | 0.23% | $1.42M |
Exome asset management | 172.92K | 0.19% | $249.72K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Novo | 4.25M | 0.37% | 4.25M |
683 capital management | 900.00K | 0.08% | 717.21K |
Sphera funds management | 690.27K | 0.18% | 690.27K |
Blackrock funding, inc. /de | 9.21M | 0.00% | 583.32K |
Millennium management | 795.97K | 0.00% | 536.19K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ecor1 capital | 11.33M | 0.61% | -8.04M |
State street | 2.68M | 0.00% | -2.82M |
Cormorant asset management, lp | - | - | -2.60M |
Silverarc capital management | - | - | -1.59M |
Goldman sachs group | 802.37K | 0.00% | -1.16M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Novo | 4.25M | 0.37% | 4.25M | $6.08M |
Sphera funds management | 690.27K | 0.18% | 690.27K | $987.09K |
Mackenzie financial | 91.96K | 0.00% | 91.96K | $129.69K |
Susquehanna fundamental investments | 91.85K | 0.00% | 91.85K | $131.35K |
Sei investments | 69.53K | 0.00% | 69.53K | $99.42K |
Sold Out
Holder | Change |
---|---|
Capital performance advisors llp | -11.00 |
Nelson, van denburg & campbell wealth management group | -22.00 |
Jones financial companies lllp | -200.00 |
Nordwand advisors | -1.50K |
Pacer advisors | -1.72K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 130 | 7.44% | 101,397,402 | -12.65% | 82 | 0.92% | 58 | 13.73% | 39 | 21.88% |
Sep 30, 2024 | 121 | -3.20% | 116,077,343 | 1.64% | 94 | 1.07% | 52 | -17.46% | 32 | -11.11% |
Jun 30, 2024 | 125 | -2.34% | 114,205,327 | -2.80% | 94 | 0.99% | 63 | -12.50% | 36 | - |
Mar 31, 2024 | 128 | 17.43% | 117,492,765 | 3.79% | 97 | 1.10% | 72 | 41.18% | 36 | 2.86% |
Dec 31, 2023 | 109 | -18.05% | 113,199,475 | -0.47% | 93 | 0.97% | 51 | -16.39% | 35 | -20.45% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard US Total Market Shares ETF | 3.47M | 2.78% | - |
Vanguard Total Stock Mkt Idx Inv | 3.47M | 2.78% | - |
iShares Russell 2000 ETF | 2.49M | 2.00% | -21.61K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.52M | 1.22% | - |
Fidelity Small Cap Index | 1.14M | 0.91% | -21.33K |
State St Russell Sm/Mid Cp® Indx SL Cl I | 839.38K | 0.67% | - |
State St Russell Sm/Mid Cp® Indx NL Cl C | 839.38K | 0.67% | - |
Vanguard Explorer Inv | 614.97K | 0.50% | - |
HealthInvest Sustainable Healthcare E | 538.62K | 0.44% | - |
iShares Russell 2000 Growth ETF | 523.40K | 0.42% | -2.49K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jan 16, 2025 | Mandelia Ashish | VP, Chief Accounting Officer | Sell | $2.06K |
Jan 16, 2025 | Protopapas Anna | - | Sell | $5.01K |
Jan 16, 2025 | Lowinger Timothy B | SVP, Chief Sci.&Tech. Officer | Sell | $4.67K |
Jan 16, 2025 | Huber Martin H. Jr. | President, CEO | Sell | $2.62K |
Jan 16, 2025 | DeSchuytner Brian | SVP, COO & CFO | Sell | $4.91K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 18 |
2024 Q4 | - | 11 |
2024 Q3 | - | 1 |
2024 Q2 | - | - |
2024 Q1 | - | 7 |
MRSN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools